Concepedia

David Lonergan

DL

1

Publications

20

Citations

1

H-Index

2022

Active since

Affiliations

BioTheryX (United States)(Current)

David Lonergan is an author at BioTheryX (United States) specializing in cancer research, oncology, and tumor biology.

Top concepts

Publications per year

2022–2022

1

Publications

1

BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.

Aparajita H. Chourasia, Hannah Majeski, Angela Pasis et al. · Journal of Clinical Oncology · 2022 · 20 citations

, , +21

Rows per page

1–1 of 1